VWA8 Human Pre-designed siRNA Set A contains three designed siRNAs for VWA8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VWC2 Human Pre-designed siRNA Set A contains three designed siRNAs for VWC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VWCE Human Pre-designed siRNA Set A contains three designed siRNAs for VWCE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VWDE Human Pre-designed siRNA Set A contains three designed siRNAs for VWDE gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VWF Human Pre-designed siRNA Set A contains three designed siRNAs for VWF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VXN Human Pre-designed siRNA Set A contains three designed siRNAs for VXN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

W123, a FTY720 analog, is a competitive sphingosine 1-phosphate type 1 (S1P1) receptor antagonist. W123 is measured by GTPγS activation, MAPK recruitment, cell migration, and ligand-induced receptor internalization[1].

WAAG-3R TFA is a biological active peptide. (Aggrecanases belong to the ADAMTS (A disintegrin and metalloprotease with thrombospondin motif) family of proteases. Aggrecanases cleave aggrecan, the major structural component of cartilage. Aggrecanase-1 (ADAMTS-4) is a major aggrecanase in human osteoarthritic cartilage. This FRET peptide was used in an ADAMTS-4 (Aggrecanase-1) assay. Ex/Em = 340/420 nm.)[1].

WAAG-3R TFA is a biological active peptide. (Aggrecanases belong to the ADAMTS (A disintegrin and metalloprotease with thrombospondin motif) family of proteases. Aggrecanases cleave aggrecan, the major structural component of cartilage. Aggrecanase-1 (ADAMTS-4) is a major aggrecanase in human osteoarthritic cartilage. This FRET peptide was used in an ADAMTS-4 (Aggrecanase-1) assay. Ex/Em = 340/420 nm.)[1].

WAAG-3R TFA is a biological active peptide. (Aggrecanases belong to the ADAMTS (A disintegrin and metalloprotease with thrombospondin motif) family of proteases. Aggrecanases cleave aggrecan, the major structural component of cartilage. Aggrecanase-1 (ADAMTS-4) is a major aggrecanase in human osteoarthritic cartilage. This FRET peptide was used in an ADAMTS-4 (Aggrecanase-1) assay. Ex/Em = 340/420 nm.)[1].

WAC Human Pre-designed siRNA Set A contains three designed siRNAs for WAC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WAPL Human Pre-designed siRNA Set A contains three designed siRNAs for WAPL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WARS1 Human Pre-designed siRNA Set A contains three designed siRNAs for WARS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WARS2 Human Pre-designed siRNA Set A contains three designed siRNAs for WARS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WAS Human Pre-designed siRNA Set A contains three designed siRNAs for WAS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WASF1 Human Pre-designed siRNA Set A contains three designed siRNAs for WASF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WASF2 Human Pre-designed siRNA Set A contains three designed siRNAs for WASF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WASF3 Human Pre-designed siRNA Set A contains three designed siRNAs for WASF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WASHC4 Human Pre-designed siRNA Set A contains three designed siRNAs for WASHC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WASHC5 Human Pre-designed siRNA Set A contains three designed siRNAs for WASHC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WASL Human Pre-designed siRNA Set A contains three designed siRNAs for WASL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WB518 is a potent STAT3 inhibitor. WB518 effectively inhibits STAT3 activation and Keratin 17 expression. WB518 effectively alleviates imiquimod (HY-B0180) and TPA (HY-18739)-induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17[1].

WBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for WBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WBP11 Human Pre-designed siRNA Set A contains three designed siRNAs for WBP11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for WBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WBP2NL Human Pre-designed siRNA Set A contains three designed siRNAs for WBP2NL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WBP4 Human Pre-designed siRNA Set A contains three designed siRNAs for WBP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WD6305 TFA is a potent METTL3-targeted PROTAC degrader. WD6305 TFA selectively reduces the METTL3 and METTL14 complex. WD6305 TFA inhibits m6A modification and the proliferation of AML cells and promotes apoptosis. WD6305 TFA can be used for the research of leukemic[1].

WD6305 TFA is a potent METTL3-targeted PROTAC degrader. WD6305 TFA selectively reduces the METTL3 and METTL14 complex. WD6305 TFA inhibits m6A modification and the proliferation of AML cells and promotes apoptosis. WD6305 TFA can be used for the research of leukemic[1].

WD6305 TFA is a potent METTL3-targeted PROTAC degrader. WD6305 TFA selectively reduces the METTL3 and METTL14 complex. WD6305 TFA inhibits m6A modification and the proliferation of AML cells and promotes apoptosis. WD6305 TFA can be used for the research of leukemic[1].

WD6305 TFA is a potent METTL3-targeted PROTAC degrader. WD6305 TFA selectively reduces the METTL3 and METTL14 complex. WD6305 TFA inhibits m6A modification and the proliferation of AML cells and promotes apoptosis. WD6305 TFA can be used for the research of leukemic[1].

WDCP Human Pre-designed siRNA Set A contains three designed siRNAs for WDCP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDFY1 Human Pre-designed siRNA Set A contains three designed siRNAs for WDFY1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDFY2 Human Pre-designed siRNA Set A contains three designed siRNAs for WDFY2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDFY3 Human Pre-designed siRNA Set A contains three designed siRNAs for WDFY3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDFY4 Human Pre-designed siRNA Set A contains three designed siRNAs for WDFY4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDHD1 Human Pre-designed siRNA Set A contains three designed siRNAs for WDHD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDPCP Human Pre-designed siRNA Set A contains three designed siRNAs for WDPCP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDR1 Human Pre-designed siRNA Set A contains three designed siRNAs for WDR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDR11 Human Pre-designed siRNA Set A contains three designed siRNAs for WDR11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDR12 Human Pre-designed siRNA Set A contains three designed siRNAs for WDR12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDR13 Human Pre-designed siRNA Set A contains three designed siRNAs for WDR13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDR17 Human Pre-designed siRNA Set A contains three designed siRNAs for WDR17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDR18 Human Pre-designed siRNA Set A contains three designed siRNAs for WDR18 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

WDR19 Human Pre-designed siRNA Set A contains three designed siRNAs for WDR19 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.